Search
for
Sort by
Research 391–420 of 1000+
- Hair loss
- Acne and Hidden Iodides
- Spironolactone in dermatology: uses in acne and beyond
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Treatment of hyperandrogenism in women
- Telogen Effluvium Associated with Albendazole Therapy
- The clinical spectrum of parathyroid disease
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Endoscopic Browplasty
- Discrimination and Proper Use of Polygoni Multiflori Radix, Cynanchi Wilfordii Radix, and Cynanchi Auriculati Radix in Korea: A Descriptive Review
- Minimal Incision Face-Lifting
- COVID‐19, androgens, and androgenic alopecia
- Rapunzel syndrome: a rare form of trichobezoar in the stomach with some extension into the small intestine
- Medication Repurposing: New Uses for Old Drugs
- Nutritional Clinical Studies in Dermatology
- Preparation of a highly specific single chain variable fragment antibody targeting miroestrol and its application in quality control of <i>Pueraria candollei</i> by enzyme‐linked immunosorbent assay
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Endocrine disorders and hormonal therapy for adolescent acne
- The spectrum of nephrocutaneous diseases and associations
- Is there a role for dermatologists in eating disorders?
- Scalp Lifting
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Secondary amenorrhea
- Pathology in Practice
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Issues in the Treatment of Epilepsy
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database